Lactobacillus casei Secreting -MSH Induces the Therapeutic Effect on DSS-Induced Acute Colitis in Balb/c Mice |
Yoon, Sun-Woo
(Mucosal Immunology Laboratory, BioNanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Lee, Chul-Ho (Disease Model Research Center, KRIBB) Kim, Jeong-Yoon (School of Bioscience and Biotechnology, Chungnam National University) Kim, Jie-Youn (BioLeaders Corporation) Sung, Moon-Hee (BioLeaders Corporation) Poo, Har-Young (Mucosal Immunology Laboratory, BioNanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB)) |
1 | Bhardwaj, R. S., A. Schwarz, E. Becher, K. Mahnke, Y. Aragane, T. Schwarz, and T. A. Luger. 1996. Pro-opiomelanocortinderived peptides induce IL-10 production in human monocytes. J. Immunol. 156: 2517-2521 |
2 | Dieleman, L. A., M. S. Goerres, A. Arends, D. Sprengers, C. Torrice, F. Hoentjen, W. B. Grenther, and R. B. Sartor. 2003. Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52: 370-376 DOI ScienceOn |
3 | Karin, M. and A. Lin. 2002. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3: 221-227 DOI ScienceOn |
4 | Lee, J. S., H. Poo, D. P. Han, S. P. Hong, K. Kim, M. W. Cho, E. Kim, M. H. Sung, and C. J. Kim. 2006. Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J. Virol. 80: 4079- 4087 DOI ScienceOn |
5 | Luger, T. A., T. Brzoska, T. E. Scholzen, D. H. Kalden, C. Sunderkotter, C. Armstrong, and J. Ansel. 2000. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann. N.Y. Acad. Sci. 917: 232-238 DOI ScienceOn |
6 | Okayasu. I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702 DOI |
7 | Oktar, B. K., F. Ercan, B. C. Yegen, and I. Alican. 2000. The effect of alpha-melanocyte stimulating hormone on colonic inflammation in the rat. Peptides 21: 1271-1277 DOI ScienceOn |
8 | Schultz, M., C. Veltkamp, L. A. Dieleman, W. B. Grenther, P. B. Wyrick, S. L. Tonkonogy, and R. B. Sartor. 2002. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 82: 71-80 |
9 | Seegers, J. F. 2002. Lactobacilli as live vaccine delivery vectors: Progress and prospects. Trends Biotechnol. 20: 508-515 DOI ScienceOn |
10 | Lipton, J. M., H. Zhao, T. Ichiyama, G. S. Barsh, and A. Catania. 1999. Mechanisms of anti-inflammatory action of alpha-MSH peptides: In vivo and in vitro evidence. Ann. N.Y. Acad. Sci. 885: 173-182 DOI |
11 | Bantel, H., C. Berg, M. Vieth, M. Stolte, W. Kruis, and K. Schulze-Osthoff. 2000. Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am. J. Gastroenterol. 95: 3452-3457 |
12 | Rajora, N., G. Boccoli, A. Catania, and J. M. Lipton. 1997. Alpha-MSH modulates experimental inflammatory bowel disease. Peptides 18: 381-385 DOI ScienceOn |
13 | Catania, A., V. Gerloni, S. Procaccia, L. Airaghi, M. G. Manfredi, C. Lomater, L. Grossi, and J. M. Lipton. 1994. The anticytokine neuropeptide alpha-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: Comparisons with other anticytokine molecules. Neuroimmunomodulation 1: 321-328 DOI ScienceOn |
14 | Gonzalez-Rey, E., N. Varela, A. F. Sheibanie, A. Chorny, D. Ganea, and M. Delgado. 2006. Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 103: 4228-4233 DOI ScienceOn |
15 | Hogaboam, C. M., B. A. Vallance, A. Kumar, C. L. Addison, F. L. Graham, J. Gauldie, and S. M. Collins. 1997. Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J. Clin. Invest. 100: 2766-2776 DOI ScienceOn |
16 | Cotta, M. A. and T. R. Whitehead. 1993. Regulation and cloning of the gene encoding amylase activity of the ruminal bacterium Streptococcus bovis. Appl. Environ. Microbiol. 59: 189-196 |
17 | Kojouharoff, G., W. Hans, F. Obermeier, D. N. Männel, T. Andus, J. Schölmerich, V. Gross, and W. Falk. 1997. Neutralization of tumor necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulfate sodium-induced colitis in mice. Clin. Exp. Immunol. 107: 353-358 DOI |
18 | Catania, A. and J. M. Lipton. 1993. Alpha-Melanocyte stimulating hormone in the modulation of host reactions. Endocr. Rev. 14: 564-576 |
19 | Barbara, G., Z. Xing, C. M. Hogaboam, J. Gauldie, and S. M. Collins. 2000. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 46: 344-349 DOI ScienceOn |
20 | Siegmund, B., F. Rieder, S. Albrich, K. Wolf, C. Bidlingmaier, G. S. Firestein, et al. 2001. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. J. Pharmacol. Exp. Ther. 296: 99-105 |
21 | Narita, J., K. Okano, T. Kitao, S. Ishida, T. Sewaki, M. H. Sung, H. Fukuda, and A. Kondo. 2006. Display of alphaamylase on the surface of Lactobacillus casei cells by use of the PgsA anchor protein, and production of lactic acid from starch. Appl. Environ. Microbiol. 72: 269-275 DOI ScienceOn |
22 | Papadakis, K. A. and S. R. Targan. 2000. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51: 289-298 DOI ScienceOn |
23 | Podolsky, D. K. 1991. Inflammatory bowel disease. N. Engl. J. Med. 325: 928-937 DOI ScienceOn |
24 | Tien, M. T., S. E. Girardin, B. Regnault, L. Le Bourhis, M. A. Dillies, J. Y. Coppée, R. Bourdet-Sicard, P. J. Sansonetti, and T. Pédron. 2006. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J. Immunol. 176: 1228-1237 DOI |
25 | Blumberg, R. S., L. J. Saubermann, and W. Strober. 1999. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11: 648-656 DOI ScienceOn |
26 | Vowinkel, T., T. J. Kalogeris, M. Mori, C. F. Krieglstein, and D. N. Granger. 2004. Impact of dextran sulfate sodium load on the severity of inflammation in experimental colitis. Dig. Dis. Sci. 49: 556-564 DOI ScienceOn |
27 | Shanahan, F. 2001. Probiotics in inflammatory bowel disease. Gut 48: 609 DOI ScienceOn |
28 | Borruel, N., M. Carol, F. Casellas, M. Antolín, F. de Lara, E. Espín, J. Naval, F. Guarner, and J. R. Malagelada. 2002. Increased mucosal tumor necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51: 659-664 DOI ScienceOn |
29 | Colombo, G., R. Buffa, M. T. Bardella, L. Garofalo, A. Carlin, J. M. Lipton, and A. Catania. 2002-2003. Anti-inflammatory effects of alpha-melanocyte stimulating hormone in celiac intestinal mucosa. Neuroimmunomodulation 10: 208-216 DOI ScienceOn |
30 | Rajora, N., G. Boccoli, D. Burns, S. Sharma, A. P. Catania, and J. M. Lipton. 1997. Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. J. Neurosci. 17: 2181-2186 DOI |
31 | Vowinkel, T., M. Mori, C. F. Krieglstein, J. Russell, F. Saijo, S. Bharwani, et al. 2004. Apolipoprotein A-IV inhibits experimental colitis. J. Clin. Invest. 114: 260-269 DOI |
32 | Mimura, T., F. Rizzello, U. Helwig, G. Poggioli, S. Schreiber, et al. 2004. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114 DOI ScienceOn |
33 | Krieglstein, C. F., W. H. Cerwinka, A. G. Sprague, F. S. Laroux, M. B. Grisham, V. E. Koteliansky, N. Senninger, D. N. Granger, and A. R. de Fougerolles. 2002. Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis. J. Clin. Invest. 110: 1773-1782 DOI |
34 | Steidler, L., W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, and E. Remaut. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355 DOI |
35 | Gantz, I., Y. Konda, T. Tashiro, Y. Shimoto, H. Miwa, G. Munzert, S. J. Watson, J. DelValle, and T. Yamada. 1993. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268: 8246-8250 |
36 | Maaser, C., K. Kannengiesser, C. Specht, A. Lugering, T. Brzoska, T. A. Luger, W. Domschke, and T. Kucharzik. 2006. Crucial role of the melanocortin receptor MC1R in experimental colitis. Gut 55: 1415-1422 DOI ScienceOn |
37 | Matsumoto, S., T. Hara, T. Hori, K. Mitsuyama, M. Nagaoka, N. Tomiyasu, A. Suzuki, and M. Sata. 2005. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the downregulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 140: 417-426 DOI |
38 | Fichtner-Feigl, S., I. J. Fuss, J. C. Preiss, W. Strober, and A. Kitani. 2005. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. J. Clin. Invest. 115: 3057-3071 DOI ScienceOn |
39 | Dubertret, L., C. Lebreton, and R. Touraine. 1982. Neutrophil studies in psoriatics: In vivo migration, phagocytosis and bacterial killing. J. Invest. Dermatol. 79: 74-78 DOI ScienceOn |